203 related articles for article (PubMed ID: 29297580)
1. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
[No Abstract] [Full Text] [Related]
2. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
Opolski MP; Kepka C; Wojakowski W; Witkowski A
Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
[No Abstract] [Full Text] [Related]
3. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
[No Abstract] [Full Text] [Related]
4. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
[No Abstract] [Full Text] [Related]
5. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
[No Abstract] [Full Text] [Related]
6. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
[No Abstract] [Full Text] [Related]
7. Serial 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side-Branch by Second-Generation Drug-Eluting Absorbable Metal Scaffold (from the BIOSOLVE-II Trial).
Ozaki Y; Garcia-Garcia HM; Hideo-Kajita A; Kuku KO; Haude M; Ince H; Abizaid A; Tölg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Escaned J; Waksman R
Am J Cardiol; 2019 Apr; 123(7):1044-1051. PubMed ID: 30683424
[TBL] [Abstract][Full Text] [Related]
8. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S;
JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807
[No Abstract] [Full Text] [Related]
9. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
10. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
[TBL] [Abstract][Full Text] [Related]
11. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
[TBL] [Abstract][Full Text] [Related]
12. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
13. Thrombotic Left Main Coronary Artery Occlusion Treated With Bioresorbable Scaffold.
Camacho Freire SJ; Gómez Menchero AE; Garrido JR; Rojas ML; Piris RC; Díaz Fernández JF
Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 35797656
[No Abstract] [Full Text] [Related]
14. First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
Rizik DG; Shah MG; Burke RF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):899-901. PubMed ID: 27545489
[TBL] [Abstract][Full Text] [Related]
15. Bioresorbable vascular scaffolds in left main coronary artery disease.
Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
[TBL] [Abstract][Full Text] [Related]
16. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
Danson E; Bhindi R; Hansen P
Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
[No Abstract] [Full Text] [Related]
17. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
18. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
Piraino D; Buccheri D; Andolina G
Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
[No Abstract] [Full Text] [Related]
19. A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance.
Boeder NF; Koepp T; Dörr O; Bauer T; Mattesini A; Elsässer A; Möllmann H; Blachutzik F; Achenbach S; Ghanem A; Hamm CW; Nef HM
Int J Cardiol; 2016 Oct; 220():706-10. PubMed ID: 27393853
[TBL] [Abstract][Full Text] [Related]
20. Acute Treatment and 5-Year Follow-up of Longitudinal Deformation of a Bioresorbable Scaffold.
Creaney CS; Hanratty CG; Christensen MK; Walsh SJ
J Invasive Cardiol; 2021 Apr; 33(4):E318-E319. PubMed ID: 33794484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
